AM1241 Research Linked Morphine Tolerance to Spinal Phosphatase and MAPK Changes
A mechanistic study linked AM1241 coadministration to restoration of spinal phosphatase proteins and reduced MAPK phosphorylation during repeated morphine exposure. The findings propose a pathway for modifying tolerance, rather than establishing a cannabis treatment for patients.
The study examined opposing signaling processes
Repeated morphine reduced MKP-1 and MKP-3 protein expression while increasing phosphorylation of p38 and ERK1/2 and levels of several inflammatory mediators. Kinases and phosphatases affect protein phosphorylation in opposite directions, so these measurements addressed regulation rather than simply counting receptors.
The CB2 agonist modified the molecular pattern
AM1241 alleviated the reduction in MKP proteins and reduced phosphorylated MAPK and inflammatory factors. Triptolide reversed the reported AM1241 effect on MKP downregulation. That intervention supports involvement of the proposed pathway, but should not be described as proving an exclusively selective mechanism.
Molecular restoration is not a clinical outcome
The authors suggested that phosphatase induction could promote MAPK dephosphorylation and thereby reduce tolerance-related processes. The supplied abstract does not establish human treatment efficacy, a dosing strategy or comparative safety. AM1241 is a research CB2 agonist, not marijuana, THC or a dispensary product.
The useful question is how repeated opioid exposure interacts with cannabinoid signaling at a specified molecular step. Phosphatase expression, phosphorylation and cytokine levels should remain distinct from pain relief and functional improvement. This study supplies mechanistic evidence rather than a prescription.
Related: interpreting cannabis tolerance claims.
Research cited
Kong Q; Tian S; Ma C; Wang G; Zhang M. Cannabinoid Receptor Type 2 Agonist Reduces Morphine Tolerance via Mitogen Activated Protein Kinase Phosphatase Induction and Mitogen Activated Protein Kinase Dephosphorylation. Neuroscience (2022). doi:10.1016/j.neuroscience.2021.11.007. Findings discussed from the study abstract.
